Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
about
The associations between Parkinson's disease and cancer: the plot thickensDiametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunologyDiabetes and risk of Parkinson's disease: an updated meta-analysis of case-control studiesThe risk of amyotrophic lateral sclerosis after cancer in U.S. elderly adults: a population-based prospective study.Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study.Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis.Dopamine inhibits the function of Gr-1+CD115+ myeloid-derived suppressor cells through D1-like receptors and enhances anti-tumor immunity.The link between Parkinson's disease and breast and prostate cancers: A meta-analysis.Cancer and Dementia: It's Complicated.The Relationship between Parkinson Disease and Brain Tumor: A Meta-Analysis.The association between Parkinson's disease and melanoma: a systematic review and meta-analysis.Parkinson's disease and cancer: A register-based family studyRisk of lung cancer in Parkinson's diseaseCancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studiesInverse association between cancer and neurodegenerative disease: review of the epidemiologic and biological evidence.Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical review.PARKIN Inactivation Links Parkinson's Disease to Melanoma.Cutaneous malignant melanoma and Parkinson disease: Common pathways?Associations between cancer and Parkinson's disease in U.S. elderly adults.Association of cancer and Alzheimer's disease risk in a national cohort of veterans.Cancer in Parkinson's disease.Potential Roles of Peripheral Dopamine in Tumor Immunity.Association between Parkinson's disease and risk of prostate cancer in different populations: An updated meta-analysis.Inverse and direct cancer comorbidity in people with central nervous system disorders: a meta-analysis of cancer incidence in 577,013 participants of 50 observational studies.ATP13A2/PARK9 regulates endo-/lysosomal cargo sorting and proteostasis through a novel PI(3, 5)P2-mediated scaffolding function.The common PARK8 mutation LRRK2G²⁰¹⁹S is not a risk factor for breast cancer in the absence of Parkinson's disease.Presenilin Mutation Suppresses Lung Tumorigenesis via Inhibition of Peroxiredoxin 6 Activity and Expression.Biological and Clinical Implications of Comorbidities in Parkinson's Disease.Mortality in Parkinson's disease: a 38-year follow-up study.Parkinson's disease and colorectal cancer risk-A nested case control study.Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease.
P2860
Q26778641-AFF1D594-CDD0-401A-B41D-8E03D16F1715Q26782139-2324820D-6339-4F43-B0FE-38A338C0E746Q28538916-A113E034-6AA6-4989-84B0-387774A301FFQ33934628-292DA2E8-649B-4E71-8CF9-58FEC13262A8Q33946187-CE7EA8D3-3E55-4F08-A961-E6BAABA17871Q35195815-A24E9C42-2213-4A3D-9D8C-0E7F357FE8B2Q35227738-D67A14F9-6E31-4A6B-ADCC-2B3E5B48A300Q35410531-E4B8A13C-DA7B-4815-B3E4-8EF85B7B1DDCQ35625177-4F0AAA8E-2429-4326-8E6D-95164BF2E57DQ36169142-D356FF3A-7C71-449A-B616-6FF5E2C9A372Q36243422-9ED59E8D-5C89-4F91-8A74-7480E87E9273Q37396182-33DFF5B4-F86D-4E3F-81CD-30049FE26FD4Q37718366-CB97BA2C-07ED-4063-B579-B594D7B8EF24Q37736881-2392D59A-244A-4376-ABF7-BF73007D568BQ38239053-54D264EC-1FF4-4D29-BAAF-BB7E033B87F4Q38538492-C92FAB53-BBF9-4CCF-BB45-D86EB0E5B499Q38810658-3F7BD446-682E-4FE4-B1E8-113E06D3F64DQ38985873-4CAA259C-2CF5-4EBF-96CF-1DD7307C47F2Q39910785-5D90A443-24EE-48F3-84ED-898EBA3EBA20Q40121614-5AD957F3-521F-4EF3-9A42-64498FAD4467Q41655737-AEA0EEDC-4394-4B06-A5C4-B0C9B6EF3B05Q41721674-C21655E7-1ADF-4D76-AB16-B809114290D9Q42677271-3BFC7569-9348-4390-B1D8-10B6E1931E7DQ45297171-D05EE35D-289C-47FE-AD9D-79C9F0A98DC5Q45865997-952D026C-8C24-46E9-92DE-A487D7E9E8CBQ46633577-9427681D-6EE1-4D54-8E8D-40AD6C81F7C8Q47122996-FF497FD3-F35B-44FC-8D47-8F9C68A5D07BQ47137783-ACDFD559-6762-44C9-A5A4-117CB947CCF5Q50246267-EC8158FF-AD5C-4A7E-A5EB-50F73CEC714AQ54334574-9D2D3667-E6CE-429B-9A5E-E1DD119411B6Q55014055-F7A4AF7F-9928-4DD7-A6F2-951421802CCC
P2860
Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
@en
type
label
Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
@en
prefLabel
Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
@en
P2860
P50
P356
P1476
Malignant melanoma, breast cancer and other cancers in patients with Parkinson's disease.
@en
P2093
Christina Funch Lassen
Søren Friis
P2860
P304
P356
10.1002/IJC.27443
P577
2012-03-22T00:00:00Z